<DOC>
	<DOCNO>NCT00690443</DOCNO>
	<brief_summary>Evaluate efficacy combination therapy AEGR-733 plus atorvastatin 20 mg versus monotherapy serum lipoproteins 4 8 week therapy . The primary efficacy parameter percent change LDL-C 8 week therapy .</brief_summary>
	<brief_title>Evaluate Safety Efficacy AEGR-733 Atorvastatin v Atorvastatin Monotherapy Hypercholesterolemia</brief_title>
	<detailed_description>Following 35-day washout current lipid-lowering medication ( ) adherence low-fat diet , subject receive either atorvastatin 20 mg 8 week , OR AEGR-733 2.5 mg + atorvastatin 20 mg 4 week follow AEGR-733 5 mg + atorvastatin 20 mg 4 additional week . During entire study , subject instruct follow low-fat/low cholesterol diet limit alcohol consumption -/ &lt; 1 drink per day .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>M/F 1870 01 risk factor , mean LDLC / &gt; 160 / &lt; 250 mg/dL ( Visit 2 &amp; 3 ) 2+ risk factor , mean LDLC / &gt; 130 &amp; / &lt; 250 mg/dL ( Visit 2 &amp; 3 ) Fasting mean TGs / &lt; 400 mg/dL Understanding compliance protocol sign consent Females pregnant , lactating , CBP use acceptable contraceptive method previous 3 month Uncontrolled hypertension &gt; 180/95 screen Hx chronic renal insufficiency ( serum creatinine &gt; 2.5 mg/dL ) Hx liver disease transaminases &gt; 1.5 X ULN Positive Hepatitis B C Major surgery within past 3 mo Cardiac insufficiency define functional Class IIClass IV Hx malignancy within previous 5 year Participation another investigational drug study within past 6 wks Serious unstable medical psychological condition Regular alcohol use &gt; 1 drink per day Regular consumer grapefruit juice medication know metabolized CYP 3A4 Use lipidlowering med ( washout permit ) Acute CVD Diabetes Mellitus Fasting glucose &gt; 110 mg/dL BMI / &gt; 40 kg/m2 Significant gastrointestinal symptom IBS Use fish oil , niacin , herbal wt . loss product ( washout permit )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Hyperlipidemia</keyword>
</DOC>